封面
市场调查报告书
商品编码
1588569

全球动态血压计市场 - 2024-2031

Global Ambulatory Blood Pressure Monitors Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年,全球动态血压监测仪市场规模达到12.0亿美元,预计2031年将达到24.3亿美元,2024-2031年预测期间复合年增长率为9.2%。

动态血压监测 (ABPM) 是一种诊断方法,可在患者进行日常活动时在 24 小时内定期测量血压。与传统的办公室测量相比,这种方法可以更精确地描述血压变化,因为它记录了白天和晚上不同时间的波动。

动态血压监测(ABPM) 设备由一个便携式监测器组成,该监测器与戴在手臂或手腕上的袖带相连,按指定的时间间隔自动充气以捕获血压读数。的一种有价值且彻底的方法。提供有关血压变化的连续、即时资料,提高诊断精度,并使医疗保健提供者能够做出明智的治疗决策,最终在管理高血压方面带来更好的患者结果。

市场动态:

司机

高血压盛行率上升

全球动态血压监测仪市场的需求是由多种因素所驱动的。高血压盛行率的增加是推动动态血压监测(ABPM)市场的关键因素。由于全球有数百万人受到影响,人口老化面临更大的风险,因此迫切需要可靠的血压监测解决方案。技术的进步、健康意识的提高以及政府的支持计划进一步增加了对 ABPM 市场的需求。

高血压是全球过早死亡的重要因素。非传染性疾病的国际目标之一是在 2010 年至 2030 年间将高血压盛行率资料33%。患有高血压,其中约三分之二居住在低收入和中等收入国家。大约 46% 的成人高血压患者不知道自己的病情,只有不到一半 (42%) 得到诊断和治疗。只有 21% 的高血压患者能够控制住病情。

此外,该行业的主要参与者拥有技术进步和产品发布,这将推动动态血压监测(ABPM)市场的成长。例如,2022 年 10 月,Biobeat 透过其创新的无袖带监测技术,彻底改变了高血压患者和医疗保健提供者的 24 小时动态血压监测 (ABPM) 体验。这项进步解决了与传统血压监测方法相关的几个限制。

此外,2021 年 5 月,可穿戴远端患者监测技术领域的知名品牌 Biobeat 最近推出了一款专为连续动态血压监测 (ABPM) 而设计的新设备,该设备可以舒适地佩戴在胸部。这种先进的胸部监测设备使医疗保健专业人员能够持续追踪患者的血压,从而显着提高在传统临床环境之外监测生命征象的能力。

限制

设备成本高、报销政策有限以及与使用相关的併发症等因素预计将阻碍动态血压监测(ABPM)市场。

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 高血压盛行率上升
    • 限制
      • 设备成本高
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章:依产品类型

  • 手臂监视器
    • 数位手臂监视器
    • 无液臂监视器
    • Mercury Arm 监视器
  • 腕式监视器(数位腕式监视器)

第 7 章:按操作类型

  • 自动监控器
  • 半自动监测仪
  • 手动监视器

第 8 章:最终用户

  • 医院和专科诊所
  • 家庭护理设置
  • 门诊手术中心 (ASC)

第 9 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Spacelabs Healthcare.
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • BOSCH + SOHN GmbH Co. KG.
  • SunTech Medical, Inc.
  • Schiller AG
  • Baxter International Inc (Welch Allyn)
  • BPL Medical Technologies
  • A&D Company
  • Microlife Corporation
  • CONTEC MEDICAL SYSTEMS CO., LTD
  • Vaso Corporation

第 12 章:附录

简介目录
Product Code: MD784

Overview

The global Ambulatory blood pressure monitors market reached US$ 1.20 billion in 2023 and is expected to reach US$ 2.43 billion by 2031 growing with a CAGR of 9.2% during the forecast period 2024-2031.

Ambulatory blood pressure monitoring (ABPM) is a diagnostic method that measures a patient's blood pressure at regular intervals over 24 hours while they carry out their usual daily activities. This approach offers a more precise depiction of blood pressure variations compared to conventional office measurements, as it records fluctuations at different times throughout the day and night.

Ambulatory blood pressure monitoring (ABPM) devices consist of a portable monitor linked to a cuff worn on the arm or wrist, which automatically inflates at designated intervals to capture blood pressure readings Ambulatory blood pressure monitoring is a valuable and thorough method for assessing and managing hypertension. Delivering continuous, real-time data on blood pressure variations, improves diagnostic precision and enables healthcare providers to make well-informed treatment decisions, ultimately leading to better patient outcomes in managing hypertension.

Market Dynamics: Drivers

Rising prevalence of hypertension

The demand for the global ambulatory blood pressure monitors market is driven by multiple factors. The increasing prevalence of hypertension is a key factor propelling the ambulatory blood pressure monitoring (ABPM) market. With millions of individuals affected worldwide and an aging population at greater risk, there is an urgent demand for reliable blood pressure monitoring solutions. Advances in technology, rising health awareness, and supportive government programs further demand for the ABPM market.

Hypertension is a significant contributor to premature mortality globally. One of the international goals for noncommunicable diseases is to achieve a 33% reduction in the prevalence of hypertension between 2010 and 2030. As per WHO data in March 2023, an estimated 1.28 billion adults aged 30 to 79 years worldwide suffer from hypertension, with approximately two-thirds residing in low- and middle-income countries. About 46% of adults with hypertension are unaware of their condition, and less than half (42%) have been diagnosed and treated. Only 21% of those with hypertension manage to keep it under control.

Moreover, key players in the industry have technological advancements and product launches that would drive this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in October 2022, Biobeat is revolutionizing the 24-hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients and healthcare providers through its innovative cuffless monitoring technology. This advancement addresses several limitations associated with traditional blood pressure monitoring methods.

Also, in May 2021, Biobeat, a prominent name in wearable remote patient monitoring technologies, has recently unveiled a new device specifically designed for continuous ambulatory blood pressure monitoring (ABPM) that can be worn comfortably on the chest. This advanced chest-monitoring device allows healthcare professionals to continuously track patients' blood pressure, significantly improving the ability to monitor vital signs outside conventional clinical environments.

Restraints

Factors such as the high costs of devices, limited reimbursement policies, and complications associated with use are expected to hamper the ambulatory blood pressure monitoring (ABPM) market.

Segment Analysis

The global ambulatory blood pressure monitors market is segmented based on product type, operation type, end-user, and region.

The arm monitors segment accounted for approximately 73.2% of the global ambulatory blood pressure monitors market share

The arm monitors segment is expected to hold the largest market share over the forecast period. Arm monitors are widely regarded as more accurate than wrist monitors for measuring blood pressure. They use a standard cuff that wraps around the upper arm, which is the recommended site for obtaining reliable readings. This level of accuracy makes them the preferred option for clinicians who need precise data for diagnosis and treatment.

Additionally, arm ambulatory blood pressure monitoring (ABPM) devices have been extensively utilized in clinical settings for many years. Their established presence in hospitals and clinics lends credibility to their use among healthcare professionals, leading to a continued preference for these devices over newer wrist models. Advancements in ambulatory blood pressure monitoring (ABPM) technology have greatly changed the field of blood pressure measurement, resulting in the creation of more compact and user-friendly devices, such as wrist and arm monitors.

Moreover, key players in the industry introduce innovative products and approvals that would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, one of the major players SunTech Medical launched the Oscar 2 ambulatory blood pressure monitor is esteemed as the leading device in 24-hour ambulatory blood pressure monitoring (ABPM).

It is designed to deliver essential diagnostic data that traditional in-clinic and home blood pressure monitors often miss, making it an invaluable resource for healthcare professionals. The device emphasizes patient comfort through its patented Orbit ABPM cuff, which is designed with a soft and flexible material that fits snugly around the arm. This design allows patients to wear the monitor for long durations without discomfort, encouraging greater compliance with monitoring protocols.

Similarly, The BPro EVO from HealthSTATS International is a third-generation ambulatory blood pressure monitor (ABPM) that integrates several advanced features aimed at improving patient monitoring and enhancing data accuracy.

Also, in October 2024, Huawei introduced the Watch D2 a smartwatch that sets itself apart with its sophisticated health monitoring features, particularly through its Ambulatory Blood Pressure Monitoring (ABPM) capability. This technology allows users to continuously monitor their blood pressure around the clock, providing critical insights into their cardiovascular health.

Geographical Analysis

North America accounted for approximately 43.2% of the global ambulatory blood pressure monitors market share

North America region is expected to hold the largest market share over the forecast period. The high prevalence of hypertension in North America significantly influences the ambulatory blood pressure monitors (ABPM) market. Hypertension, commonly referred to as high blood pressure, elevates the risk of heart disease and stroke, which are among the leading causes of death in the United States.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in August 2022, CardiAI Inc. officially launched its new 24-hour ambulatory blood pressure monitoring system, named BPAro. This device is compact and portable, manufactured in Germany, and designed for individuals to monitor their blood pressure. Utilizing Bluetooth technology, BPAro wirelessly collects data, which is then securely uploaded to a cloud database for analysis.

Market Segmentation

By Product Type

  • Arm Monitors
    • Digital Arm Monitors
    • Aneroid Arm Monitors
    • Mercury Arm Monitors
  • Wrist Monitors (Digital Wrist Monitors)

By Operation Type

  • Automatic Monitors
  • Semi-Automatic Monitors
  • Manual Monitors

By End-User

  • Hospitals & Specialty Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the ambulatory blood pressure monitors market include Spacelabs Healthcare., BOSCH + SOHN GmbH Co. KG., SunTech Medical, Inc., Schiller AG, Baxter International Inc. (Welch Allyn, BPL Medical Technologies, A&D Company, Microlife Corporation, CONTEC MEDICAL SYSTEMS CO., LTD, and Vaso Corporation among others.

Key Developments

  • In March 2024, seca Screen 300 ABPM was introduced as a state-of-the-art ambulatory blood pressure monitor (ABPM), recognized for its cutting-edge features and significant validation. It is distinguished as the first ABPM device in the world to achieve successful validation under the European Society of Hypertension International Protocol (ESH-IP) 2010 standards.

Why Purchase the Report?

  • To visualize the global ambulatory blood pressure monitors market segmentation based on product type, operation type, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points on the ambulatory blood pressure monitors market in all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global ambulatory blood pressure monitors market report would provide approximately 62 tables, 51 figures, and 183 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Operation Type
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Hypertension
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Arm Monitors*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Digital Arm Monitors
    • 6.2.4. Aneroid Arm Monitors
    • 6.2.5. Mercury Arm Monitors
  • 6.3. Wrist Monitors (Digital Wrist Monitors)

7. By Operation Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 7.1.2. Market Attractiveness Index, By Operation Type
  • 7.2. Automatic Monitors *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Semi-Automatic Monitors
  • 7.4. Manual Monitors

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals & Specialty Clinics *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Homecare Settings
  • 8.4. Ambulatory Surgical Centers (ASCs)

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Spacelabs Healthcare. *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. BOSCH + SOHN GmbH Co. KG.
  • 11.3. SunTech Medical, Inc.
  • 11.4. Schiller AG
  • 11.5. Baxter International Inc (Welch Allyn)
  • 11.6. BPL Medical Technologies
  • 11.7. A&D Company
  • 11.8. Microlife Corporation
  • 11.9. CONTEC MEDICAL SYSTEMS CO., LTD
  • 11.10. Vaso Corporation

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us